Clinical Trial

Development and Implementation of Mobile Antibiograms to Optimize Empirical Antibiotic Prescriptions Among Prescribers in Tertiary Hospitals in Tanzania

Study acronym: AMR; AMU; DDD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Antimicrobial resistance (AMR) is a critical issue, especially in Africa, with resistance to common antibiotics reaching 100% in some areas. In Tanzania, limited access to culture tests and antibiograms forces healthcare providers to rely on experience for prescribing, heightening AMR risks. This study aims to determine the effectiveness of mobile antibiograms in optimizing empirical antibiotic therapy in tertiary hospitals in Tanzania.
Trial Details
NCT Number NCT07393308
Lead Sponsor Muhimbili University of Health and Allied Sciences
Conditions Antimicrobial Prescribing Practices, Antimicrobial Resistance (AMR)
Enrollment 300 participants
Start Date 2026-02-01
Primary Completion 2027-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-06